Fierce Biotech May 3, 2024
QuidelOrtho has been looking for a new CEO since its board of directors fired the medical testing company’s last chief earlier this year. Now it’s been able to lure Brian Blaser, Abbott’s former diagnostics head, out of retirement.
Blaser will take the reins as president and CEO starting next week, May 6, two days before QuidelOrtho is set to detail its first quarter earnings.
The company’s board ousted long-time boss Douglas Bryant in late February, following his tenure of 15 years, after its 2023 financials posted an 8% drop in sales—equating to a drop of about $270 million, it was the company’s first full-year report since its megadeal combining Quidel and Ortho Clinical Diagnostics.
“Brian brings over 25...
Today's Sponsors
Today's Sponsor
Topics: Medical Devices